Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer. - Wikidata - awgldk - TriplyDB

Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.

Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.

http://www.wikidata.org/entity/Q33755725

about

Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.Central nervous system metastasis from breast cancer.Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.

P2860

Q30279153-512AEE69-35C3-4CF1-BF31-27EC9467304E Q34960132-0F68A829-0688-4617-80C6-62EA968BBC2C Q38792519-E1D03A76-7F43-46D8-959A-AF71C65DAA60

P2860

Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.

http://www.wikidata.org/entity/Q33755725

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Rationale for the use of upfro ...... metastases from breast cancer.

@ast

Rationale for the use of upfro ...... metastases from breast cancer.

@en

type

label

Rationale for the use of upfro ...... metastases from breast cancer.

@ast

Rationale for the use of upfro ...... metastases from breast cancer.

@en

prefLabel

Rationale for the use of upfro ...... metastases from breast cancer.

@ast

Rationale for the use of upfro ...... metastases from breast cancer.

@en

P1433

Q33755725-5E1971F2-0F25-4524-BFF4-DADD1E2EBD6E

P1476

Q33755725-88E21846-3789-4098-976A-92AC83BFFECB

P2093

Q33755725-184A1DE5-9BB5-405C-BBC3-B6294AD14FA2

Q33755725-1B453DAA-3822-44FB-8DDE-FAA19E63F4F0

Q33755725-203C6F7D-18E9-4903-AB42-66B4C092DA33

Q33755725-2B55CC4A-F920-4F57-AD26-D3B18E1965E1

Q33755725-5D3DBB57-E837-43B4-A12F-E8E5D6BCF951

Q33755725-897C5038-CABE-47A6-AF06-8B217A32EC82

Q33755725-B69FDD75-B227-483D-B3B5-C9A3E0755960

Q33755725-BB38F0B2-9F1E-4760-8975-4B4362E7CFCB

Q33755725-D31B955D-C138-405D-A061-67CC026283F8

Q33755725-DA21DD4B-8A28-4DC0-90EC-EB15B08ECC43

P275

Q33755725-E105B51C-6F75-4044-9603-822CCC3C1B48

P2860

Q33755725-06719598-653A-41E8-B49D-C23157C949F1

Q33755725-0A4AEFE1-EC59-4E64-97FF-50C460653D64

Q33755725-10C706D9-798F-4E2A-A332-81B0C2DD4B53

Q33755725-128749AE-9C65-4DF9-8096-3A2CFAF15D99

Q33755725-166C19B6-166C-4DCE-B920-9EB2B7AE4BEC

Q33755725-1AB8E01A-BBFD-4959-94E8-F44CB43D3A6B

Q33755725-20BCBF2D-E06B-4F80-92D4-7E797ACC343E

Q33755725-22180DB7-8C25-4A75-8153-B17D5D3E9CC1

Q33755725-25701F94-27E5-4B8B-8B2F-AAC742BB734C

Q33755725-280A3001-B9FE-4A44-9A71-C8B3D6E3FDA4

P304

Q33755725-7CB47466-D385-4B3C-910F-28AC2E559ECB

P31

Q33755725-82ACF9C3-04F6-4990-A8EE-BC61A76AC4C2

Q33755725-BD6A4B2B-EDC8-440F-8274-AEB2DF5292BA

P356

Q33755725-558E2872-90F9-44E8-B64B-DC60D64E8D1C

P407

Q33755725-5061C42A-182D-4C43-8E77-BE37FF123767

P433

Q33755725-E0ED21E9-7D86-4E59-BAED-1CE5FDA65EEB

P478

Q33755725-BA2420DE-5E0D-40A2-AE45-D1E203189B90

P5008

Q33755725-739EFA35-DE88-41EC-A448-775BA51B8B99

P577

Q33755725-C7E3872B-C239-4F64-9E1B-F7E988FBD09B

P5875

Q33755725-D82FE059-4F8E-4E4B-AA64-9BABBD1178C2

P698

Q33755725-8E02A529-2218-49C1-8DB9-587C4FB531C7

P921

Q33755725-CBBFC7AB-199C-4EC3-BB72-6AB45565E5D2

Q33755725-CFFE5CD5-D0B7-43C4-9908-43A7ACFAE2AE

Q33755725-D98323AD-2CA5-43D2-8BD2-1B0FC33094F3

Q33755725-ED77A8FB-05A9-4E64-8104-82BA20DDC1B4

Q33755725-EFC93CAA-D693-45CB-BDFC-5B655D79B24F

P932

Q33755725-F7401EB3-45AB-4B4C-A69B-2ABB366D7AB3

P356

P1433

International Journal of Molecular Sciences

P1476

Rationale for the use of upfro ...... metastases from breast cancer.

@en

P2093

Agnes V Tallet

http://www.w3.org/2001/XMLSchema#string

Antoine F Carpentier

http://www.w3.org/2001/XMLSchema#string

Antony Gonçalves

http://www.w3.org/2001/XMLSchema#string

David Azria

http://www.w3.org/2001/XMLSchema#string

Emilie Le Rhun

http://www.w3.org/2001/XMLSchema#string

Fabrice Barlesi

http://www.w3.org/2001/XMLSchema#string

Frédéric Dhermain

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Spano

http://www.w3.org/2001/XMLSchema#string

Philippe Metellus

http://www.w3.org/2001/XMLSchema#string

Sophie Taillibert

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Radiation-induced dementia in patients cured of brain metastases.

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras.

P304

8138-8152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS15058138

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262226264

http://www.w3.org/2001/XMLSchema#string

P698

24815073

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

P932

4057724

http://www.w3.org/2001/XMLSchema#string